Home » 2017 » August (Page 3)

Historic ‘living drug’ gets go-ahead

Historic ‘living drug’ gets go-ahead

Image copyright Novartis The US has approved the first treatment to redesign a patient’s own immune system so it attacks cancer. The regulator – the US Food and Drug Administration…

Trial raises Parkinson’s therapy hope

Trial raises Parkinson’s therapy hope

Image copyright SPL Scientists have restored nerve cells destroyed by a condition similar to Parkinson’s disease, in monkeys. The Japanese team hope their work could lead to stem cell trials…

Cyber-flaw affects 745,000 pacemakers

Cyber-flaw affects 745,000 pacemakers

Image copyright Getty Images Image caption Wireless models of St Jude-branded pacemakers can now receive a firmware update A total of 745,000 pacemakers have been confirmed as having cyber-security issues…

Pap Smear Guidelines: Here’s How Often You Actually Need a Pap Smear

Pap smears used to be a no-brainer: You’d see your ob/gyn for your yearly wellness check and would get an annual Pap in the process. But recommendations changed in the…

I Worked Out at a Women-Only Gym to See If I’d Feel More Comfortable

For female exercisers in big-box gyms, it’s a fairly common occurrence: a not-so-subtle tap on your shoulder, followed by a dude motioning for you to take off your headphones. When…

15 High Neck Sports Bras to Show Off Your Shoulders

NEW SELF Meal Plans Easy-to-make Recipes. No Guesswork. Source Article from https://www.self.com/gallery/high-neck-sports-bras…

These 14 Drawings Perfectly Capture How Magical Living Alone Can Be

NEW SELF Meal Plans Easy-to-make Recipes. No Guesswork. Source Article from https://www.self.com/story/living-alone-is-magical…

Egypt promotes birth control to fight rapid population growth

CAIRO (Reuters) – Egypt is pushing to educate people in rural areas on birth control and family planning in a bid to slow a population growth rate that President Abdel…

Novartis gene therapy approval signals new cancer treatment era

(Reuters) – Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the…

Otonomy pulls plug on ear drug, shares nosedive

(Reuters) – Otonomy Inc said on Wednesday it suspended developing its drug for Meniere’s disease, a chronic disorder of the inner ear, after it failed a late-stage trial, sending the…